Re: Apabetalone......a Calculated Risk
in response to
by
posted on
Apr 06, 2019 06:56PM
,,hummm,,,,I would say it is more than just speculation,,,,,,,,,we do have many articles supporting the science around the select inhibition of BET protiens. So my perspective is as experienced RVX shareholders we speculate more at this time in respect to Managements' ability to have designed a trial that will actually fullfill the expectations of shareholder, patients and the governing bodies!